Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "multiple cellular targets" refers to a broad strategy or category in pharmacology and biomedicine, denoting drugs, biologics, or interventions that affect several distinct molecular or cellular components at once, rather than acting on a single, well-defined target such as a specific receptor, enzyme, or ion channel. This can be relevant in situations such as cancer, where the microenvironment and disease process involve complex, interacting networks of cells and signaling pathways, and interventions may aim to disrupt several aspects of this network at once for therapeutic effect. However, "multiple cellular targets" does not identify a unique, canonical molecular entity and should not be treated as a single, structured target entry[1]. This entry is considered "incorrect" in the context of creating a structured molecular target database, as it is not a distinct molecule, receptor, or gene product, but rather a descriptive term for a mechanism or strategy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cellular targets.